Abortifacient efficacy of aqueous-acetone extracts of Adenopus breviflorus Benth seed in female albino rats

listen audio

Study Justification:
– The study aimed to evaluate the abortifacient potential of the aqueous-acetone extract of Adenopus breviflorus Benth Seed on the reproductive health of matured female albino rats.
– The study monitored the indices of dysfunctions in the reproductive system and evaluated the effects on antioxidant levels, reproductive hormones, and histology of uteri tissues.
– The study provided scientific evidence to support the abortifacient activity of the seed extract.
Highlights:
– The study found that the aqueous-acetone extract of Adenopus breviflorus Benth Seed had abortifacient activity in female albino rats.
– The extract significantly reduced reproductive hormones such as FSH, LH, prolactin, progesterone, and estrogen.
– The phytochemical composition of the seed extract was characterized, revealing the presence of benzene-mesitylene and pseudocumene as the most predominant compounds.
– The study demonstrated the safety of the seed extract at a dose of 5000 mg/kg BWT.
Recommendations:
– Further research should be conducted to determine the mechanism of action of the seed extract and its potential use as an abortifacient in humans.
– Clinical trials should be conducted to evaluate the efficacy and safety of the seed extract in human subjects.
– Regulatory authorities should consider the potential use of Adenopus breviflorus Benth Seed extract as an alternative abortifacient option.
Key Role Players:
– Researchers and scientists specializing in reproductive health and herbal medicine.
– Ethical review boards and regulatory authorities responsible for approving and monitoring clinical trials.
– Medical professionals and gynecologists involved in reproductive health care.
Cost Items for Planning Recommendations:
– Research funding for further studies, including laboratory equipment, animal models, and research personnel.
– Clinical trial expenses, including recruitment of human subjects, medical examinations, and data collection.
– Regulatory compliance costs, including ethical review board fees and documentation.
– Marketing and distribution costs if the seed extract is approved for commercial use.

The strength of evidence for this abstract is 7 out of 10.
The evidence in the abstract is moderately strong, but there are some areas for improvement. The study design includes both in vivo and in vitro experiments, which adds credibility to the findings. The use of a control group and multiple experimental groups also strengthens the study. The evaluation of reproductive hormones and histology of uteri tissues provides additional evidence for the abortifacient activity of the seed extract. However, there are some limitations. The sample size is relatively small, with only 6 animals in each experimental group. Additionally, the abstract does not provide information on the statistical significance of the results. To improve the evidence, the study could be replicated with a larger sample size and statistical analysis should be included to determine the significance of the findings.

The present study evaluated the abortifacient potential of aqueous-acetone extract of Adenopus breviflorus Benth Seed on the reproductive health of matured female albino rats by monitoring the indices of dysfunctions in reproductive system. Prior to the conduction of the fertility studies, the oral acute toxicity of the seed extract was evaluated for autonomic, behavioral and neurological changes, within 24 h to determine the LD50.The influence of aqueous-acetone extract of Adenopus breviflorus Benth Seed was evaluated for antioxidant, reproductive hormones and histology of uteri tissues primarily to monitor effects in female fertility. Female rats exhibiting thick clump of spermatozoa in their vaginal smear were randomly selected and used for the study to determine the abortifacient activity of the seed extract. Parameters such as number of live and dead fetuses, anogenital distance (AGD) and crown rump length (CRL), and the variation in birth weight of liters and gestation period between control and experimental animals were determined. The phytochemical composition of the seed extract was characterized by Gas Chromatography and Mass Spectrophotometry for the identification of phytochemical of toxic or therapeutic effects. Symptoms similar to clinical toxicity such as salivation, respiratory distress, weight loss and change in appearance of hair were noticed at concentrations above 1600 mg/kg BWT, there was no maternal mortality at any period of the experiment. There were changes in the behavioural, neurological and autonomic profile in groups with doses greater than 1600 mg/kg BWT. The LD50 evaluation showed that the aqueous-acetone extract of the seed was safe at dose of 5000 mg/kg BWT. The GC–MS characterization of the aqueous-acetone seed revealed isomeric derivatives of benzene-mesitylene and pseudocumene 4.28 g/100 g of sample) and 5.85 g/100 g of sample respectively as most predominant phytochemicals in the seed extract which demonstrated maternal toxicity. The effects on the female reproductive hormones of the treated animals revealed that FSH, LH and prolactin were significantly reduced (p < 0.05) in all the treated groups by the extract. Progesterone (PH) and estrogen (EH) were also reduced significantly. The study revealed scientific evidence in support of the abortifacient activity of seed extract that was significantly corresponding to the discovered phytochemical compounds.

Adenopus breviflorus Benth leaves and pods were collected from a domestic garden in Akure, Ondo State, Nigeria during sunrise and aerated until extraction. The method used for the preparation of aqueous-acetone extract of Adenopus breviflorus Benth seed was described thus, the leaves and tendril were separated from the pod and both were discarded, and the pod was broken by improvised mechanical press. Mixture was then preserved inside an air tight polythene bag to soften the endocarp and allow easy expulsion of the seed from the pod. The seeds were washed with water to remove slippery components and oven dried at 40 °C for 72 h to a constant weight. The dried seeds were then pulverized using Beltone Luinohun Blender/Miller III (model MS-223, Taipei, Taiwan). The powdered material was stocked in a sealed plastic container from which 1000 g was mixed with 1.0 L of distilled water:acetone (80:20) and stirred for 48 h at room temperature. This was then filtered with a sieve of considerable pore seize. The filtrate was concentrated using rotary evaporator and freeze drying machines to give dried residue (brownish black caked). The presence of various plant constituents in the seed extract was determined by preliminary phytochemical screening [5]. The content was concentrated to 1 mL for gas chromatography analysis and 1 μl injected into the injection port of GC. The GC equipment used was HP 6890 powered with HP chemstation Rev. A09.01 (1206) software. The split ratio will be 20:1, the carrier gas was nitrogen at inlet temperature of 250 °C with a column type of HP INNOWax and column dimensions of 30 m x0.25 mm x0.25 μm. The oven program parameters include initial temperature at 60 °C, first ramping at 12 °C/min for 20 min, maintain for 2 min and second ramping at 15 °C/min for 3 min, maintained for 8 min. The detector used FID at 320 °C at hydrogen pressure 22 psi and compressed air of 35 psi. Adult female Wistar albino rats, weighing 210−230 g were received from experimental Animal Care Center (University of Ilorin, Kwara State. Nigeria). All animals were maintained under controlled conditions of temperature (22 ± 1 °C), humidity (50–55 %) and light (12 h light/12 h dark cycle). They were acclimatized to the laboratory conditions for 14 days before the start of the experiment. Animals had free access to rat chow and drinking water. All experimental procedures were conducted in accordance with the Ethical Regulation and Guide for the Care and Use of Laboratory Animals [6]. Healthy female albino rats were deprived of food and water for 4 h and subjected to lethal dose at 50 % (LD50) and acute toxicity studies as described by Lorke, (1983) [7]. They were divided into 6 groups of 5 animals each and kept in separate cages during the experiment. The control group received food and water ad libitum. Groups 2–6 received suspension of extract of Adenopus breviflorus Benth seed orally at the doses of 10, 100, 1000, 1600, 2900 and 5000 mg/kg BWT daily. The rats were observed initially for 2 h for autonomic, behavioral and neurological changes, and for another 24 h to determine the LD50. The plant extract was tested in female albino rats for abortifacient activity as designed and reported by Khanna et al. [8]. The female rats in proestrous phase were caged with males of proven fertility in the ratio of 2:1, in the evening and examined the following day for the evidence of copulation. Female rats exhibiting thick clump of spermatozoa in their vaginal smear were separated and that day was designated as Day 1 of pregnancy. These rats were randomly distributed into 4 groups, Control group and 3 Experimental groups of 6 animals each. On Day 10 of pregnancy, animals were laprotomised under light ether anesthesia using sterile conditions. The two horns of uteri were examined to determine the implantation sites. Thereafter the abdominal wound was sutured in layers. The extract to be tested was then fed to confirmed pregnant rats, at doses of 100 (Group 2), 1000 (Group 3) and 1600 (Group 4) mg/kg body weight once daily by an intragastric (i. g.) soft rubber catheter from Day 11 up to the 15th day of pregnancy. The animals were allowed to go full term. After delivery the pups were counted and the abortifacient activity of extract was evaluated. The following parameters were computed: Number of live and dead fetuses; The anogenital distance (AGD) and crown rump length (CRL) of litters were measured by using a measuring tape. The variations in birth weight of litters and gestation period between control and experimental animal were also determined to check the abortive effect of Adenopus breviflorus Benth seed [9]. Animals in each group were completely anaesthetized and then sacrificed by cervical decapitation. The ovary and uterus were carefully removed and weighed using digital electronic balance. Blood samples were collected via cardiac puncture into non-anticoagulant tubes. The uteri and ovaries were rinsed in ice-cold 1.15 % potassium chloride solution and homogenized in 0.1 M potassium phosphate buffer (pH 7.4) by using a Teflon homogenizer. The homogenized tissues were centrifuged at 3000g for 10 min at 4 °C [6]. The sera of the control and experimental groups of female were analyzed for estrogen, progesterone, luteinizing and follicle stimulating hormone level with AccuLite master CLIA VAST Enabled kit. A Thiobarbituric Acid Reactive Substances (TBARS) assay kit (Randox) was used to measure the lipid peroxidation product MDA equivalent. One hundred microliters of homogenate was mixed with 2.5 mL reaction buffer (provided by the kit) and heated at 95 °C for 60 min. After the mixture had cooled, the absorbance of the supernatant was measured at 532 nm using a spectrophotometer. The lipid peroxidation product MDA levels are expressed in terms of nmoles MDA/mg protein using molar extinction coefficient of MDA- thiobarbituric chromophore (1.56 × 105/M/cm). The concentration of GSH was measured using standard laboratory method [10]. Homogenate was mixed with 0.2 M Tris buffer, pH 8.2 and 0.1 mL of 0.01 M Ellman's reagent, (5, 5′-dithiobis-(2-nitro-benzoic acid)) (DTNB). Each sample tube was centrifuged at 3000g at room temperature for 15 min. The absorbance of the clear supernatants was measured using spectrophotometer at 412 nm in one centimeter quarts cells. The activity of GST was measured using standard laboratory method [11]. The reaction mixture consisted of 1.0 mM GSH, 1.0 mM CDNB, 0.1 M phosphate buffer (pH 7.4) and 0.1 mL of PMS in a total volume of 3.0 mL. The change in absorbance was recorded at 340 nm by using Shimadzu spectrophotometer UV-1601 and enzyme activity was calculated as nmol of CDNB conjugate formed min−1  mg−1 protein using molar extinction coefficient of 9.6 × 103/M/cm. The activity of SOD in cells was estimated using standard laboratory method [12], with the aid of nitroblue tetrazolium as the indicator. Superoxide anions are generated by the oxidation of hydroxylamine hydrochloride. The reduction of nitroblue tetrazolium to blue formazon mediated by superoxide anions was measured 560 nm under aerobic conditions. Addition of superoxide dismutase inhibits the reduction of nitroblue tetrazolium and the extent of inhibition is taken as a measure of enzyme activity. The SOD activity was expressed as units/mg protein as compared to a standard curve. This was carried out using the manufacturer protocol of Randox Total Protein Kit [13]. 1 mL of reagent R1(Sodium hydroxide (100 mmol/l), sodium-potassium tartrate (16 mmol/l), Potassium iodide (15 mmol/l) and copper II sulphate (6 mmol/l)) was added to 0.02 mL of the test sample, the mixture was incubated at 25 °C and the absorbance was then measured against the reagent blank at a wavelength of 546 nm. All values are expressed as mean ± standard deviation. Statistical evaluation was done using One Way Analysis of Variance (ANOVA) followed by Duncan’s Multiple Range Test (DMRT). The significance level was set at p<0.05.

N/A

Based on the provided information, it appears that the study is focused on evaluating the abortifacient potential of the aqueous-acetone extract of Adenopus breviflorus Benth seed on the reproductive health of female albino rats. The study involves various parameters such as monitoring reproductive system dysfunctions, evaluating antioxidant activity, analyzing reproductive hormones, and examining the histology of uteri tissues. The study also includes the characterization of phytochemical compounds present in the seed extract.

However, it is important to note that the information provided does not directly mention innovations or recommendations for improving access to maternal health. To provide accurate recommendations, it would be helpful to have more information on the specific aspects of maternal health access that need improvement.
AI Innovations Description
The study described in the provided text evaluates the abortifacient potential of an aqueous-acetone extract of Adenopus breviflorus Benth Seed on the reproductive health of matured female albino rats. The study monitored various parameters such as reproductive hormones, histology of uteri tissues, number of live and dead fetuses, anogenital distance, crown rump length, birth weight of litters, and gestation period. The phytochemical composition of the seed extract was also characterized. The study found evidence supporting the abortifacient activity of the seed extract, which was correlated with the identified phytochemical compounds.

To develop this research into an innovation to improve access to maternal health, the following recommendations can be considered:

1. Further Research: Conduct additional research to validate the findings of this study and explore the potential use of Adenopus breviflorus Benth Seed extract in a controlled clinical setting. This would involve testing the extract on a larger sample size of animals and potentially on human subjects.

2. Safety and Efficacy Studies: Conduct comprehensive safety and efficacy studies to determine the appropriate dosage, potential side effects, and long-term effects of using Adenopus breviflorus Benth Seed extract as an abortifacient. This would involve conducting preclinical trials and eventually clinical trials on human subjects.

3. Regulatory Approval: Seek regulatory approval from relevant authorities, such as health agencies and ethics committees, before conducting further research or clinical trials. Compliance with ethical guidelines and regulations is crucial to ensure the safety and well-being of participants.

4. Collaboration: Collaborate with healthcare professionals, researchers, and organizations specializing in maternal health to gather diverse perspectives and expertise. This collaboration can help in designing and implementing effective interventions and ensuring the innovation aligns with existing healthcare systems.

5. Education and Awareness: Develop educational materials and awareness campaigns to inform women and healthcare providers about the potential benefits and risks of using Adenopus breviflorus Benth Seed extract as an abortifacient. This would involve disseminating accurate and evidence-based information to empower individuals to make informed decisions about their reproductive health.

6. Access and Affordability: Consider the accessibility and affordability of the innovation. Explore strategies to make the Adenopus breviflorus Benth Seed extract or any derived products affordable and accessible to women in low-resource settings, where maternal health services may be limited.

7. Monitoring and Evaluation: Establish a system for monitoring and evaluating the implementation and impact of the innovation. This would involve tracking outcomes such as maternal health outcomes, access to services, and any potential adverse effects. Regular evaluation can help identify areas for improvement and ensure the innovation is meeting its intended goals.

It is important to note that the development of any innovation in the field of maternal health should prioritize the safety and well-being of women and adhere to ethical standards and regulations.
AI Innovations Methodology
Based on the provided information, it seems that the study is focused on evaluating the abortifacient potential of the aqueous-acetone extract of Adenopus breviflorus Benth seed on the reproductive health of matured female albino rats. The study includes various parameters such as monitoring reproductive system dysfunctions, evaluating the toxicity of the seed extract, assessing the effects on reproductive hormones and histology of uteri tissues, and determining the abortifacient activity of the seed extract.

To improve access to maternal health, it is important to consider innovations that can address the specific challenges faced in this area. Here are a few potential recommendations:

1. Telemedicine and Mobile Health (mHealth) Solutions: Implementing telemedicine and mHealth solutions can help improve access to maternal health services, especially in remote or underserved areas. These technologies can enable pregnant women to receive prenatal care, access medical advice, and receive reminders for appointments and medication through their mobile devices.

2. Community-Based Maternal Health Programs: Establishing community-based programs that provide comprehensive maternal health services can help reach women who may face barriers to accessing healthcare. These programs can include prenatal care, education on nutrition and hygiene, and postnatal care, all delivered within the community setting.

3. Maternal Health Vouchers: Introducing voucher programs that provide financial assistance for maternal health services can help reduce the financial burden on pregnant women and increase their access to quality care. These vouchers can cover services such as prenatal check-ups, delivery, and postnatal care.

4. Training and Empowerment of Community Health Workers: Investing in the training and empowerment of community health workers can enhance their capacity to provide maternal health services at the grassroots level. These workers can conduct prenatal visits, provide health education, and refer women to higher-level facilities when necessary.

To simulate the impact of these recommendations on improving access to maternal health, a methodology could include the following steps:

1. Define the target population: Identify the specific population or region where the recommendations will be implemented. Consider factors such as demographics, geographic location, and existing healthcare infrastructure.

2. Collect baseline data: Gather data on the current state of maternal health in the target population, including indicators such as maternal mortality rates, access to prenatal care, and utilization of healthcare services.

3. Design intervention scenarios: Develop different scenarios that represent the implementation of the recommendations. For example, one scenario could involve the introduction of telemedicine and mHealth solutions, while another scenario could focus on community-based maternal health programs.

4. Simulate the impact: Use modeling techniques to simulate the potential impact of each intervention scenario on access to maternal health. This could involve analyzing factors such as changes in maternal mortality rates, increased utilization of prenatal care services, and improvements in health outcomes.

5. Evaluate cost-effectiveness: Assess the cost-effectiveness of each intervention scenario by considering factors such as implementation costs, potential savings in healthcare expenses, and the overall impact on maternal health outcomes.

6. Refine and prioritize recommendations: Based on the simulation results and cost-effectiveness analysis, refine and prioritize the recommendations that are most likely to have a significant impact on improving access to maternal health.

7. Implement and monitor: Implement the recommended interventions and closely monitor their implementation and impact. Continuously evaluate and adjust the interventions as needed to ensure their effectiveness.

By following this methodology, policymakers and healthcare providers can make informed decisions on which innovations to prioritize and implement to improve access to maternal health.

Share this:
Facebook
Twitter
LinkedIn
WhatsApp
Email